Enthusiastic demand and a desire for something other than biotech paper have seen Venus Medtech raise HK$2.6bn (US$331m) in its IPO in Hong Kong. The company has sold 78.5 million…
Enthusiastic demand and a desire for something other than biotech paper have seen Venus Medtech raise HK$2.6bn (US$331m) in its IPO in Hong Kong. The company has sold 78.5 million…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


